I think the key point here to argue, is not whether you have to contribute, but whether anyone should be spending on private treatments abroad (including child’s parents etc).
the uk is in a fairly unique position in the world becuase of our nhs process re treatments. Whilst drugs/treatments csn be approved for use in uk through the authorisation by our regulatory body (MHRA), in exactly the same way as it may be in other countries like USA, this doesn’t mean it will be available under the nhs. The fact the nhs is a national, single body , centralised service, means we have a pretty robust state Clincial body to assess the value of new treatments as they come along. And the risk vs benefit profile can be assessed across the nation as a whole with accords to a nationwide data base and epidemiological information (e.g. how common is that illness, population group impacted etc). This is NICE. most countries simply don’t have a national organisation like this. It is way more common that those assessments are made by individual health insurance companies, who may come up with different decisions depending on what you pay for your insurance.
now on an individual level, NICE comes in for a hammering, it prevents access to nhs patients for approved and authorised treatments, available, that have been demonstrated to work in SOME people. It is pretty common for NICE to block use in nhs until much later after launches, for it to gather far more reliable population based data to effectiveness vs costs. NICES job is looking at overall population and saying overall what % of patients will benefit. And that’s an entirely different approach to individual patients deciding to purchase treatments directly themselves in countitres whether thst is the model.
so, treatments aren’t available in this country, not because necessarily they’re unsafe, but becuase on balance not enough people will be successfully treated with it, for the cost and possible side effects that impact the whole population treated.
however, in that cohort of population, there ARE people who will benefit. Just not enough for NICE to treat the population overall, at high cost, for the benefit of the small minority of “lucky” patients.
so, question then becomes, will you go private for treatments that are more likely not to work, very costly, and probably with higher side effects, Becuase you hope you will be one of lucky minority of those with positive outcomes? That’s a gamble
and of course the private providers are going to put positive spins on your individual chances to ensure you hand over the cash. providers know that “hope” is a powerful paersuasion to people, without very much hard selling at all, especially when terminal illnesses or severe disability will be the outcome
it comes down to whether you want to spend money on hope, or not spend money and rely on NICEs population reviews to decide on basis of probable outcome.
I don’t think anyone can say what the answer is to anyone in that position- unless you’ve faced such life and death decisions . If you, op, want to trust empirical studies reviewed by NICE and their decison , versus google and hope from a grieving mum, then no one has right to make you spend your hard earned cash and future security on that.
personally, I wouldn’t touch a treatment for anything NICE has not approved for use in nhs, but then I’ve worked in pharma for 40 years, and know about how regulatory process work long before it gets to NICE.
I’ve also seen the impact on family of a few families chasing down private treatments abroad that aren’t a visible in nhs, and watched them waste the last months of someone life, travelling, staying in hotels, paying loads on insurance cover becuase of high risk patent travelling, and not being at home, in their own house, surrounded by friends and family for last few months of their life. It comes down to quality not quantity of life.
as I say, HOPE is a powerful emotion. People view it as a positive little emotion. However, hope most often is a survival mechanism, to protect us from taking riskier decison to change. In these cases, the change that is often needed, is a grieving process to reach acceptance on the outcome of not chasing down treatments that will only help a lucky few. And that’s a huge emotional shift for families, especially when a child is involved. Hope is easier.